Incidence of MIS-C and Other Complications Following SARS-CoV-2 Infection Read more about Incidence of MIS-C and Other Complications Following SARS-CoV-2 Infection
COVID-19 and Disease Progression to the Severe Form: A Study on the Use of Monoclonal Antibodies Against SARS-CoV-2 Read more about COVID-19 and Disease Progression to the Severe Form: A Study on the Use of Monoclonal Antibodies Against SARS-CoV-2
Markers of Severity (CD177,S100A8 &S100A12) in Sever Acute Respiratory Syndrome Coronavirus 2(SARS-COV-2) Patients Read more about Markers of Severity (CD177,S100A8 &S100A12) in Sever Acute Respiratory Syndrome Coronavirus 2(SARS-COV-2) Patients
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies Read more about SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies
Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test (ASPIRE-2) Read more about Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test (ASPIRE-2)
A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines Read more about A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines
Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations Read more about Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations
Understanding the Long-term Impact of COVID-19 in Adults (RECOVER) Read more about Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)
Intervention to Prevent Household and Community Spread of COVID-19 Among Latinos Read more about Intervention to Prevent Household and Community Spread of COVID-19 Among Latinos
A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) or Pneumonia Read more about A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) or Pneumonia